Clinical trial
Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT00182689
Study timeline
Study start (unknown)2005-07-01Date precision: month
Registry last updated2014-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Extensive Stage Small Cell Lung Cancerunresolved
Recurrent Small Cell Lung Cancerunresolved
Interventions
sorafenib tosylateDRUG · verified · RxNorm: sorafenib tosylate
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00182689 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.